bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update

by Dale Harrison | Nov 14, 2022 | Press Releases

SAN ANTONIO–(BUSINESS WIRE)– bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment, today reported its...

bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board

by Dale Harrison | Nov 10, 2022 | Press Releases

SAN ANTONIO–(BUSINESS WIRE)– bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced Sheila Habib, MD, Director of Pulmonary Lung Nodule Clinic and the Lung Cancer Screening Program at the South Texas Veterans Health Care Systems’ Audie L. Murphy...

bioAffinity Technologies to Report Third Quarter 2022 Financial Results

by Dale Harrison | Nov 8, 2022 | Press Releases

SAN ANTONIO–(BUSINESS WIRE)– bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced that the Company will host a conference call and audio webcast on Monday, Nov. 14, 2022, at 8 a.m. ET to discuss its corporate and financial results for the...

San Antonio cancer biotech follows IPO with patent win in China

by Dale Harrison | Nov 2, 2022 | Articles, News

San Antonio cancer biotech follows IPO with patent win in China NOVEMBER 2, 2022 As published in the San Antonio Business Journal By: By W. Scott Bailey – Senior Reporter, San Antonio Business Journal The People’s Republic of China has awarded a Certificate of Patent...

bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia

by Dale Harrison | Oct 25, 2022 | Press Releases

Awarded patents protect novel porphyrin-conjugated compounds for selective delivery of cancer treatments SAN ANTONIO, TX – Oct. 25, 2022 – bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) announced the People’s Republic of China awarded a Certificate of Patent to...
« Older Entries
Next Entries »

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (136)
  • Publications (17)

Recent Posts

  • bioAffinity Technologies Appoints New Members to Board of Directors August 18, 2025
  • bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds August 14, 2025
  • bioAffinity Technologies Reports Second Quarter 2025 Results August 14, 2025
  • bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds August 13, 2025
  • bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales August 13, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.